Wound Management Technologies Joins IMCO Vendor Network to Expand Sales Nationwide
Posted on: Tuesday, 10 March 2009, 08:53 CDT
IMCO vendors are carefully selected on quality, price, service, integrity and market acceptance, as well as their exceptional support for IMCO members and their customers. Only one of 20 vendors qualify to become an IMCO vendor. Wound Care Innovation's patented advanced wound care collagen product, CellerateRx(R), was selected as a unique product that has unprecedented capabilities and benefits through all phases of wound healing and is FDA cleared for use on all wound types, except for 3rd degree burns.
"As an IMCO vendor, Wound Care Innovations joins an elite growing network of independent distributors with over 1,000 sales people to market CellerateRx throughout the U.S.," said
About IMCO
Established in 1981, IMCO is a U.S. leader in medical supply distribution. The Company has established a trusted network of the best independent distributors in the healthcare industry. With over 125 member locations throughout
For more information, visit www.imcoinc.com.
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. (OTCBB:WNDM), with its corporate headquarters in
"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
Contact: Product Information Shareholder Relations Cathy Bradshaw Lucy Singleton President Secretary 954-315-9242 817-820-7080SOURCE Wound Management Technologies, Inc.
Source: PR Newswire
Related Articles
- Reportlinker Adds Wound Care Markets, 4th. Edition, Vol. III: Surgical and Trauma Wounds Report
- Reportlinker Adds Worldwide Wound Care Markets: Total Coverage (Vol. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition Report
- Wound Management Technologies, Inc Announces Conference Plans and Presentations on Advanced Wound Care Product
- Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
- American Biotech Labs(R) Obtains FDA Approval for New Wound Care Gel Product
- American Medical Technologies, Inc. Partners with WoundEducators.com in Wound Care Certification Training Initiative
- This Report is an Essential Source for In-Depth Information and Data Relating to Republic of Korea Wound Care Management Medical Equipment Market
- Evaluate and Compare the Attractiveness of the Market in France With Wound Care Management Medical Equipment Industry Report
- PolyRemedy Raises $25 Million in Funding to Revolutionize the Delivery of Wound Care Using Robotics and Nano-Technology at the Point of Care
- Preplanning With Protocols for Skin and Wound Care in Obese Patients
User Comments (0)

RSS Feeds